Goals and Strengths
The Hematology-Oncology Fellowship Program is a highly-structured educational program with comprehensive, individualized clinical and research mentorship that offers a robust and varied clinical experience in both hematology and oncology.
Fellows benefit from our central location in the world-renowned, state-of-the-art, Texas Medical Center.
The primary goal of the program is to provide fellows an opportunity to develop the clinical and research skills necessary to become successful, independent clinical or laboratory investigators. Upon completion of this ACGME-accredited training program, fellows will meet the subspecialty certification requirements of the American Board of Pediatrics for Pediatric Hematology-Oncology. This comprehensive clinical and research training program is ideal for candidates who wish to pursue a career in academic pediatric hematology-oncology.
The training program draws on the strengths of its association with Texas Children’s Hospital, the largest children’s hospital in the country, and Baylor College of Medicine’s Department of Pediatrics, which ranks first in the United States in NIH funding among Departments of Pediatrics. Situated within Houston’s Texas Medical Center, the largest medical center in the world, the program offers numerous opportunities for laboratory and clinical research.
Some of the program’s major strengths include:
- Experienced, dedicated faculty
- A robust and varied clinical experience in both hematology and oncology in a state-of-the-art medical center
- A highly-structured educational program with comprehensive, individualized clinical and research mentorship numerous, well-funded laboratory and clinical research programs in which to receive training
- A formalized, comprehensive core curriculum in clinical research opportunities to receive graduate degrees in Basic or Clinical Research or in Public Health and Epidemiology
- Participation in formalized leadership training
- Education in writing grants for peer review
- Specific training as an “attending” physician